Review Article

Patient Preferences and Values in Decision Making for Migraines: A Systematic Literature Review

Table 5

Preferences and values for acute symptomatic treatment.

StudyTreatment processTreatment outcome

Lipton and Stewart [24]In terms of dosage form, the order of priority was tablets, nasal spray, and subcutaneous injectionEighty-seven percent of patients had expected complete pain relief after treatment, 86% had no recurrence, and 83% had rapid pain relief
Adelman et al. [25]Among the included patients, 188 chose orally disintegrating tablets, while 179 preferred conventional tablets
Pascual et al. [26]The reasons for patient preference for either of the two triptans were faster onset, duration of action, fewer adverse events, and lower price
Weidmann et al. [27]In terms of dosage form, the order of priority was tablets, nasal spray, and subcutaneous injectionRapid pain relief without adverse events
Dahlöf et al. [28]Most patients would like to continue using zolmitriptan nasal sprayRapid pain relief without adverse events
Lipton et al. [29]When selecting a triptan, the rating of efficacy attributes was clearly more important than tolerability or consistencyAbsence of pain within 1 hour was the most desired treatment outcome for migraine patients
Schoenen et al. [30]More patients preferred eletriptanRapid pain relief without recurrence
Lainez et al. [31]More patients preferred rizatriptan 10 mg wafer compared to eletriptan 40 mg tabletsRapid pain relief and return to normal activities
Dowson et al. [32]At baseline, most patients indicated a preference for conventional tablets. After trying other formulations with a faster onset of action, most patients no longer preferred conventional tabletsRapid pain relief
Diez et al. [33]More patients preferred almotriptan 12.5 mg compared to rizatriptan 10 mgRapid pain relief and return to normal activities
Lanteri et al. [34]Patients tended to use triptans and were satisfied with this treatmentFreedom from pain and rapid onset of action
Bartolini et al. [35]Most of the patients indicated a preference for triptansRapid pain relief without recurrence
Gonzalez et al. [36].No recurrence of headache
Smelt et al. [37]Patients wanted to relieve pain within 30 minutes after treatment, returned to normal activity within 1 hour, and had no recurrence of headache